IOVA iovance.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
The current EV/EBITDA multiple correlates with Iovance Biotherapeutics (IOVA) revenues from exclusive sales of AMTAGVI for the treatment of melanoma, while 0.00 serves as the base value of the parameter. Iovance Biotherapeutics (IOVA) complies with environmental regulations regarding the processing of biomaterials in its laboratories. Its first-mover status in cell therapy provides the company with multi-year patent control within the complex oncology segment.
Ringkesan rincian data analitis iovance.com (IOVA)
- rega saham lan target rega konsensus:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Iovance Biotherapeutics|IOVA - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Iovance Biotherapeutics, Inc.|IOVA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Iovance Corp|IOVA - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Iovance Biotherapeutics|Indikator likuiditas cepet iovance.com
- rincian asil keuangan lan kelipatan valuasi:
IOVA - Bathi resik taunan|Bathi mangsa ngarep Iovance Biotherapeutics|IOVA - Rasio rega pasar marang bathi resik|Pangali Forward P/E Iovance Biotherapeutics|IOVA - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Iovance Corp|IOVA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Iovance Biotherapeutics|IOVA - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan iovance.com|IOVA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Iovance Biotherapeutics
Analisis fundamental perusahaan:IOVA (Iovance)
For Iovance Biotherapeutics (IOVA), which focuses on independently launching cell therapy without M&A, the business's EV/EBITDA ratio serves as a filter for model viability given the capital-intensive nature of the industry. The ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization allows for the filtering of speculative noise, revealing whether the asset is truly undervalued or if there is a risk of capital freeze in the event of margin compression.
Analisis pesaing Iovance Biotherapeutics
ImmunityBio Corp - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Immunocore Corp (IMCR) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|JANX: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan RCUS (arcusbio.com)|ZYME: Pangali EV/EBITDA|TNGX - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Immatics Corp|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Xencor Inc. (XNCR)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Compass Therapeutics (CMPX)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan replimune.com REPL|Lyell Immunopharma, Inc. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Pangali EV/EBITDA Innate Pharma SA IPHA|PYXS - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CGEN (Compugen Ltd.) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|IO Biotech, Inc. (IOBT) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan sutrobio.com (STRO)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan INKT|HOWL - Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan IMMX (Immix Biopharma, Inc.)|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan ALXO|Pangali EV/EBITDA CUE (Cue Biopharma)|Nilai bisnis marang bathi operasional sadurunge panyusutan PDSB|Sonnet BioTherapeutics Holdings Inc. - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MAIA Biotech|Liminatus Pharma Corp (LIMN) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|LAVA Therapeutics - Nilai bisnis marang bathi operasional sadurunge panyusutan|NXTC (NextCure, Inc.) - Pangali EV/EBITDA|Pangali EV/EBITDA Leap Tx|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Intensity Therapeutics (INTS)|SNSE: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan|Synthetic Biologics - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Gritstone bio Inc. (GRTS) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Kineta, Inc. - Pangali EV/EBITDA|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan neximmune.com NEXI|turnstonebio.com (TSBX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vaccinex Inc. (VCNX)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan HARP
